Skip to Main Content

Author Details

Courtney Wilkins
Center for Innate Immunity and Immune Disease, University of Washington
2005
23
15
PMIDPaper TitleJournal TitlePublished Year
36939421A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.J Immunol2023
37586370Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells.Cell Chem Biol2023
31409781RIG-I-like receptors direct inflammatory macrophage polarization against West Nile virus infection.Nat Commun2019
31748228Strong T<sub>H</sub>1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy.Sci Transl Med2019
31415679STING is required for host defense against neuropathological West Nile virus infection.PLoS Pathog2019
29559569Interleukin-1β Signaling in Dendritic Cells Induces Antiviral Interferon Responses.mBio2018
30297339Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells.J Immunol2018
27933528RNA-Seq in the Collaborative Cross.Methods Mol Biol2017
28808965RNA PAMPs as Molecular Tools for Evaluating RIG-I Function in Innate Immunity.Methods Mol Biol2017
28592649Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross.G3 (Bethesda)2017
26981429Transcriptional analysis of antiviral small molecule therapeutics as agonists of the RLR pathway.Genom Data2016
27872814Transcriptional profiles of WNV neurovirulence in a genetically diverse Collaborative Cross population.Genom Data2016
27843766Identifying protective host gene expression signatures within the spleen during West Nile virus infection in the collaborative cross model.Genom Data2016
27806117A Mouse Model of Chronic West Nile Virus Disease.PLoS Pathog2016
25734423Proteomic analysis of mitochondrial-associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and organelle trafficking.PLoS One2015
26676770Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.J Virol2015
24449862Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1.Proc Natl Acad Sci U S A2014
22996292IFITM1 is a tight junction protein that inhibits hepatitis C virus entry.Hepatology2013
23300459IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling.PLoS Pathog2013
23352217Sterol-izing innate immunity.Immunity2013
20061127Recognition of viruses by cytoplasmic sensors.Curr Opin Immunol2010
20169186Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems.PLoS Pathog2010
16107852RNA interference is an antiviral defence mechanism in Caenorhabditis elegans.Nature2005
  • 1 - 23 of 23

Recommended Authors

University of Texas Medical Branch
Career Start Year 2017
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 1
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 1
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 1
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 1
Rutgers University
Career Start Year 2007
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 4
Institute of Veterinary Disease Control
Career Start Year 2006
Number of shared co-authors 2
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 2004
Number of shared co-authors 0
Institute for Genomic Medicine, Columbia University
Career Start Year 2002
Number of shared co-authors 1
University of California davis
Career Start Year 2002
Number of shared co-authors 1
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 3
NYU Grossman School of Medicine
Career Start Year 2001
Number of shared co-authors 5
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 14
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 4
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 6
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 1
University of Texas Medical Branch
Career Start Year 1998
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 2
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 5
University of Pennsylvania
Career Start Year 1993
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 3
University College London
Career Start Year 1992
Number of shared co-authors 1
Yale University
Career Start Year 1990
Number of shared co-authors 4
University of Washington
Career Start Year 1978
Number of shared co-authors 18

Collaborators

Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 20
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 11
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 7
University of North Carolina.
Co-authored papers 5
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 5
Center for Innate Immunity and Immune Disease
Co-authored papers 4
Lankenau Institute for Medical Research
Co-authored papers 4
University of North Carolina
Co-authored papers 4
University of Washington
Co-authored papers 3
Washington University School of Medicine
Co-authored papers 2
Regeneron Pharmaceuticals
Co-authored papers 2
University of North Carolina
Co-authored papers 2
Co-authored papers 2
Fred Hutchinson Cancer Research Center
Co-authored papers 2
BIO5 Institute, The University of Arizona
Co-authored papers 2
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
University of Washington
Co-authored papers 2
Knight Cancer Institute Oregon Health & Science University Portland Oregon USA.
Co-authored papers 2
University of North Carolina at Chapel Hill.
Co-authored papers 2
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 1
Co-authored papers 1
St. Jude Children's Research Hospital
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
University of Washington, USA Washington National Primate Research Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
The University of North Carolina at Chapel Hill
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1